ArticleOrthopaedic journal of sports medicine2025
Global Variations in Surgical Techniques for Primary Anterior Cruciate Ligament Reconstruction at Minimum 2-Year Follow-up: A Systematic Review of Randomized Clinical Trials.
Article in Orthopaedic journal of sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- What does a failure in anterior cruciate ligament reconstruction really mean? An integrative view.Knee surgery & related research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Regional differences in primary anterior cruciate ligament (ACL) reconstruction (ACLR) remain largely unknown. Purpose: To systematically review the literature examining Level 1 and Level 2 studies to identify global differences in surgical techniques associated with primary ACLR. Study Design: Scoping review; Level of evidence, 1. Methods: A literature search was conducted following the 2020 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines using keywords and Boolean phrases in Embase, Cochrane, and PubMed on October 25, 2024. A total of 741 articles were identified. The inclusion criteria were as follows: Level 1 and Level 2 human studies reporting on primary ACLR, with a minimum 2-year follow-up. Studies were categorized into 3 regions (Europe, Asia, and North America), and patient characteristics, surgical details, and graft failure/revision rates were compared between regions using parametric/nonparametric tests. Results: In the 141 studies (n = 11,048 patients) identified, the mean patient age of 28.9 years (range, 13-79 years) and the follow-up of 53.8 months (range, 24-252 months) did not differ by region. Hamstring tendon (HT) autograft use was associated with Asian studies, while bone-patellar tendon-bone (BPTB) and quadriceps tendon (QT) autograft use were associated with European and North American studies. Suspensory fixation was the most common femoral fixation method (n/N = 4605/10,403 patients; 44%), associated with use in Asian studies and with HT autografts, whereas bioabsorbable screws were the most common overall method of tibial fixation (n/N = 4470/10,235 patients; 44%). Graft failure (n/N = 399/8314; 4.8%) was reported less often in Asian than in North American studies. Revision surgery (n/N = 222/6065; 3.7%) was reported less often in Asian than European and North American studies. Conclusion: Our study demonstrated that European and North American studies were associated with BPTB and QT autografts, whereas studies from Asia were associated with HT autografts. Femoral suspensory fixation and tibial bioabsorbable screw were most commonly reported. Graft failure and revision rates were broadly similar between regions. These findings suggest potential cultural and training differences worldwide to improve patient treatment outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.